Moreover, the relationship between positive PRMT5/EZH2 expression and clinicopathological parameters, including gender, age, tumor size, tumor stage, lymph node status and distant metastasis, was summarized in Table S4. The gene discussed is PRMT5; the disease is neoplasm.